Trials / Completed
CompletedNCT00990743
Tolerance and Effect on Intraocular Pressure After Administration of SYL040012
Phase I Study With SYL040012. Tolerance and Effect on Intraocular Pressure
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Sylentis, S.A. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether SYL040012 is safe for the treatment of ocular hypertension and glaucoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SYL040012 | Administration of single and multiple doses of SYL040012 in ophthalmic drops solution |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2010-06-01
- Completion
- 2010-06-01
- First posted
- 2009-10-07
- Last updated
- 2010-10-22
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT00990743. Inclusion in this directory is not an endorsement.